Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric G Davis

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Surgeon|June 3, 2015
Machine perfusion: not just for marginal kidney donorsRobert M Cannon, Guy N Brock, R Neal Garrison, et al.
The Journal of Emergency Medicine|December 30, 2008
Catastrophic gastrointestinal injury due to battery acid ingestionDeanna D H Franke, Eric G Davis, Dustin R Woods, et al.
Journal of the American College of Surgeons|February 3, 2020
Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease ExceptionRobert M Cannon, Eric G Davis, David S Goldberg, et al.
Transplantation|September 14, 2019
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?Robert M Cannon, Jayme E Locke, Babak J Orandi, et al.
The American Surgeon|July 9, 2018
Correlation of Biliary Colic in the Absence of Cholelithiasis with Pancreaticobiliary ObstructionNeal Bhutiani, Amber N Brown, Eric G Davis, et al.
Surgery|August 4, 2014
Factors predictive of readmission after hepatic resection for hepatocellular carcinomaCharles W Kimbrough, Steven C Agle, Charles R Scoggins, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 27, 2016
Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantationNeil E Crittenden, Laura A Buchanan, Christina M Pinkston, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Surgeon|June 3, 2015
Machine perfusion: not just for marginal kidney donorsRobert M Cannon, Guy N Brock, R Neal Garrison, et al.
The Journal of Emergency Medicine|December 30, 2008
Catastrophic gastrointestinal injury due to battery acid ingestionDeanna D H Franke, Eric G Davis, Dustin R Woods, et al.
Journal of the American College of Surgeons|February 3, 2020
Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease ExceptionRobert M Cannon, Eric G Davis, David S Goldberg, et al.
Transplantation|September 14, 2019
Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?Robert M Cannon, Jayme E Locke, Babak J Orandi, et al.
The American Surgeon|July 9, 2018
Correlation of Biliary Colic in the Absence of Cholelithiasis with Pancreaticobiliary ObstructionNeal Bhutiani, Amber N Brown, Eric G Davis, et al.
Surgery|August 4, 2014
Factors predictive of readmission after hepatic resection for hepatocellular carcinomaCharles W Kimbrough, Steven C Agle, Charles R Scoggins, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 27, 2016
Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantationNeil E Crittenden, Laura A Buchanan, Christina M Pinkston, et al.
Pageof 2